CAS: 635318-55-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Pomaglumetad methionil anhydrous REF: TM-T11907CAS: 635318-55-7 | 98% | 1,386.00 €~7,067.00 € | Tue 07 Jan 25 |
 | LY2140023 REF: 3D-FL32644CAS: 635318-55-7 | Min. 95% | To inquire | Thu 16 Jan 25 |
 | LY 2140023 REF: TR-L073880CAS: 635318-55-7 | - - - | 22,507.00 € | Tue 18 Feb 25 |
Pomaglumetad methionil anhydrous
CAS:635318-55-7
LY2140023, potential schizophrenia treatment, is an oral prodrug of LY404039, a selective mGlu2/3 agonist.
Formula:
C12H18N2O7S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
366.41
Ref: TM-T11907
| 10mg | 1,386.00 € | ||
| 25mg | 2,957.00 € | ||
| 50mg | 4,649.00 € | ||
| 100mg | 7,067.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
LY2140023
CAS:635318-55-7
LY2140023 is a novel drug that acts as an agonist of the metabotropic glutamate receptor …
Formula:
C12H18N2O7S2
Purity:
Min. 95%
Molecular weight:
366.41 g/mol
Ref: 3D-FL32644
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025
LY 2140023
Controlled ProductCAS:635318-55-7
Formula:
C12H18N2O7S2
Color and Shape:
Neat
Molecular weight:
366.41
Ref: TR-L073880
| 75mg | 22,507.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
